Infectomics Screening for Novel Antiviral Drug Targets
Identifieur interne : 001350 ( Ncbi/Checkpoint ); précédent : 001349; suivant : 001351Infectomics Screening for Novel Antiviral Drug Targets
Auteurs : Yuan Liu ; Qi Yin ; Yao Yuan ; Wenyong Yang ; Chuangui Jiang ; Canhua HuangSource :
- Drug Development Research [ 0272-4391 ] ; 2012.
Abstract
Preclinical Research
Infectomics, a novel way to globally and comprehensively understand the interactions between microbial pathogens and their hosts, has significantly expanded understanding of the microbial infections. The infectomics view of viral–host interactions on the viral perspective principally focuses on gene acquisition, deletion, and point mutation, while traditional antiviral drug discovery concentrates on viral encoding proteins. Recently, high‐throughput technologies, such as mass spectrometry‐based proteomics, activity‐based protein profiling, microarray analysis, yeast two‐hybrid assay, small interfering
Url:
DOI: 10.1002/ddr.21027
PubMed: NONE
PubMed Central: 7163650
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000899
- to stream Pmc, to step Curation: 000899
- to stream Pmc, to step Checkpoint: 000856
- to stream Ncbi, to step Merge: 001350
- to stream Ncbi, to step Curation: 001350
Links to Exploration step
PMC:7163650Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author><name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7163650</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163650</idno>
<idno type="RBID">PMC:7163650</idno>
<idno type="doi">10.1002/ddr.21027</idno>
<idno type="pmid">NONE</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000899</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000899</idno>
<idno type="wicri:Area/Pmc/Curation">000899</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000899</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000856</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000856</idno>
<idno type="wicri:Area/Ncbi/Merge">001350</idno>
<idno type="wicri:Area/Ncbi/Curation">001350</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001350</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Infectomics Screening for Novel Antiviral Drug Targets</title>
<author><name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
<affiliation><nlm:aff id="ddr21027-aff-0001"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Drug Development Research</title>
<idno type="ISSN">0272-4391</idno>
<idno type="eISSN">1098-2299</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Abstract</title>
<p><table-wrap id="nlm-table-wrap-1" xml:lang="en" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><col align="left" span="1"></col>
<tbody><tr><td align="left" rowspan="1" colspan="1">Preclinical Research</td>
</tr>
</tbody>
</table>
<permissions><copyright-holder>Copyright 2012 Wiley-Liss, Inc., A Wiley Company</copyright-holder>
<license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p>
</license>
</permissions>
</table-wrap>
</p>
<p>Infectomics, a novel way to globally and comprehensively understand the interactions between microbial pathogens and their hosts, has significantly expanded understanding of the microbial infections. The infectomics view of viral–host interactions on the viral perspective principally focuses on gene acquisition, deletion, and point mutation, while traditional antiviral drug discovery concentrates on viral encoding proteins. Recently, high‐throughput technologies, such as mass spectrometry‐based proteomics, activity‐based protein profiling, microarray analysis, yeast two‐hybrid assay, small interfering <styled-content style="fixed-case" toggle="no">RNA</styled-content>
screening, and micro <styled-content style="fixed-case" toggle="no">RNA</styled-content>
profiling, have been gradually employed in the research of virus–host interactions. Besides, signaling pathways and cellular processes involved in viral–host interactions provide new insights of infectomics in antiviral drug discovery. In this review, we summarize related infectomics approaches in the studies of virus–host interactions, which shed light on the development of novel antiviral drug targets screening.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Huang, Canhua" sort="Huang, Canhua" uniqKey="Huang C" first="Canhua" last="Huang">Canhua Huang</name>
<name sortKey="Jiang, Chuangui" sort="Jiang, Chuangui" uniqKey="Jiang C" first="Chuangui" last="Jiang">Chuangui Jiang</name>
<name sortKey="Liu, Yuan" sort="Liu, Yuan" uniqKey="Liu Y" first="Yuan" last="Liu">Yuan Liu</name>
<name sortKey="Yang, Wenyong" sort="Yang, Wenyong" uniqKey="Yang W" first="Wenyong" last="Yang">Wenyong Yang</name>
<name sortKey="Yin, Qi" sort="Yin, Qi" uniqKey="Yin Q" first="Qi" last="Yin">Qi Yin</name>
<name sortKey="Yuan, Yao" sort="Yuan, Yao" uniqKey="Yuan Y" first="Yao" last="Yuan">Yao Yuan</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001350 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001350 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= StressCovidV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= PMC:7163650 |texte= Infectomics Screening for Novel Antiviral Drug Targets }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:NONE" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a StressCovidV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |